Navigation Links
Endo Pharmaceuticals to Present at J.P. Morgan Annual Global High Yield & Leveraged Finance Conference
Date:2/17/2012

CHADDS FORD, Pa., Feb. 17, 2012 /PRNewswire/ -- Endo Pharmaceuticals Holdings (Nasdaq: ENDP) today announced that Mark Gottlieb, vice president and treasurer, will present a corporate overview at the J.P. Morgan Annual Global High Yield & Leveraged Finance Conference on Wednesday, February 29, 2012 at 10:20 a.m. ET.  The conference will be held at the Loews Hotel in Miami Beach, FL.

A live webcast and audio archive of the presentation will be available on the company's website at http://www.endo.com/.  Click on Investor Relations, and then the link to the Event and Presentation.  Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Endo

Endo Pharmaceuticals Holdings is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments - branded pharmaceuticals, generics and devices and services. We deliver an innovative suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology. For more information about Endo Pharmaceuticals Holdings and its businesses American Medical Systems, HealthTronics and Qualitest Pharmaceuticals, please visit http://www.endo.com/.


'/>"/>
SOURCE Endo Pharmaceuticals Holdings
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Access Pharmaceuticals MuGard Added to Nationally Ranked Childrens Hospital of Colorado Pharmacy Formulary
2. Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors
3. Omthera Pharmaceuticals, Inc. to Present at Leerink Swann 2012 Global Healthcare Conference and Citi 2012 Global Healthcare Conference
4. Jazz Pharmaceuticals to Announce 2011 Full Year and Fourth Quarter Financial Results on February 27, 2012
5. Vanda Pharmaceuticals Reports Fourth Quarter 2011 and Full Year 2011 Results
6. Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
7. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
8. Jubilant and Endo Pharmaceuticals Announce Successful Delivery of Early Milestones in Collaborative Discovery Program
9. Syndax Pharmaceuticals Announces Entinostat Enhanced Activity of Cancer Immunotherapies in Renal and Prostate Cancer Models
10. Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain
11. Prismic Pharmaceuticals Acquires Scaristas Exclusive License to Amarins Omega-3 Patents for CNS Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... MINNEAPOLIS , July 23, 2014 ... they have added 14 new vendors so far ... Creekridge,s newest vendors are from both ... mid-size domestic organizations to large, well-known multi-national companies. ... Creekridge,s diversified suite of financing products including: standard ...
(Date:7/23/2014)... , July 23, 2014  Mezzion Pharma Co. ... to evaluate the use of udenafil to treat adolescents ... ventricle heart defects. The clinical program will follow protocols ... the Pediatric Heart Network (PHN), a multi-center clinical research ... Institute (NHLBI) of the National Institutes of Health (NIH). ...
(Date:7/23/2014)... , July 23, 2014  Lightlake Therapeutics ... addiction treatments based on its expertise in opioid ... investigational new drug application ("IND") with respect to ... also announced today that it has received an ... Abuse ("NIDA"), part of the National Institutes of ...
Breaking Medicine Technology:Creekridge Capital Signs Several New Vendor Partners 2Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3
... Orthopedic Group, Inc. (NYSE: HGR ) announced that it continues ... Prosthetics of Texas , Nebraska Orthotic and Prosthetic Services, and Spectrum ... with annual revenues of $14.0 million . , ... "These companies are leaders in their communities ...
... June 22 Draeger Medical Canada, Inc. today announced ... System (AIMS) for the Capital District Health Authority and IWK Health Centre ... , , ... of the most comprehensive information technology solution for the safe delivery and ...
Cached Medicine Technology:Hanger Orthopedic Group, Inc. Announces Three Acquisitions With Annual Revenues of $14.0 Million 2Capital District Health Authority and IWK Health Centre to Implement Anesthesia Information Management System 2Capital District Health Authority and IWK Health Centre to Implement Anesthesia Information Management System 3
(Date:7/23/2014)... 23, 2014 Four hospitals affiliated with ... in the latest ranking of the country’s best hospitals ... Released online today and slated for publication in August, ... General Hospital (AGH), Forbes Hospital, Saint Vincent Hospital and ... multiple clinical specialties. , “There is no ...
(Date:7/23/2014)... WEDNESDAY, July 23, 2014 (HealthDay News) --,Jealousy may not ... showing dogs can get downright possessive when it comes ... owners showed affection toward what was actually a stuffed ... snapping or pushing the stuffed dog aside, report researchers ... This jealous streak only surfaced when owners were attending ...
(Date:7/23/2014)... In a massive effort to catalog the ... at Dana-Farber Cancer Institute, have identified four subtypes ... molecular abnormalities. They say the new classification promises ... for the third-leading cancer killer worldwide. , In ... The Cancer Genome Atlas Research Network said they ...
(Date:7/23/2014)... Texas Physical Therapy Specialists (TexPTS) is ... Westlake, Westgate, Liberty Hill, Parmer, Balcones, and Georgetown clinics ... Orthopaedic Certified Specialist (OCS) or Sports ... DPT, OCS, Tony Lauretta, PT, DPT, OCS, Jason Brown, ... Leech, PT, DPT, OCS, and Mary Grimberg, PT, DPT, ...
(Date:7/23/2014)... 2014 A therapy combining salmon fibrin injections into ... into the brain restored voluntary motor function impaired by ... Center have found. , In a study on rodents, ... turning back the developmental clock in a molecular pathway ... and providing a scaffold so that neuronal axons at ...
Breaking Medicine News(10 mins):Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3Health News:Dogs Can Get Jealous, Too 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3Health News:Gene inhibitor, salmon fibrin restore function lost in spinal cord injury 2
... it time for all community-based doctors to turn to e-prescribing ... According to Rainu Kaushal and colleagues from the Weill Cornell ... prescribing errors up to seven-fold. Their study of ... in the Journal of General Internal Medicine , published ...
... ... renowned publication, The Leading Physicians of the World. Dr. Sood will be representing the ... dermatologists from all over the globe. , ... New York, NY (PRWEB) February 22, 2010 -- As owner of Harper Dermatology ...
... ... ... ... ...
... ... ... ... ...
... proven to enhance bone density and reduce fracture incidence ... increase risk of atypical fractures of the femur when ... research presented today at the 2010 Annual Meeting of ... Bisphosphonates are designed to slow or stop the ...
... , ... best selling author David S. Linthicum kicks off the Webinar series with Best Practices in ... ... of the Leveraging Cloud Computing Within the Modern Data Center webinar series. These media ...
Cached Medicine News:Health News:Physicians click their way to better prescriptions 2Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 2Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 3Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 4Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 5Health News:Kimberly-Clark Introduces Kleenex Hand Towels 2Health News:Kimberly-Clark Introduces Kleenex Hand Towels 3Health News:Kimberly-Clark Introduces Kleenex Hand Towels 4Health News:Kimberly-Clark Introduces Kleenex Hand Towels 5Health News:Kimberly-Clark Introduces Kleenex Hand Towels 6Health News:Quantity vs. quality: Long-term use of bone-building osteoporosis drugs 2Health News:Quantity vs. quality: Long-term use of bone-building osteoporosis drugs 3Health News:Bick Group Launches Leveraging Cloud Computing Within the Modern Data Center Webinar Series 2
... achieves a secure clot, targeted to the ... hemostasis is needed, when control of bleeding ... and cautery, is ineffective or impractical., CROSSEAL* ... of human Biologically Active Component (BAC) and ...
Mastisol Liquid Adhesive is a clear, non-irritating, and non-water-soluble liquid adhesive that secures the most difficult dressings for an extended period of time. Mastisol is 7 to 10 times stickier...
... Indermil® tissue adhesive is indicated for ... laparoscopic incisions, and trauma-induced lacerations in areas ... thoroughly-cleansed, and have easily approximated skin edges. ... tissue adhesive may act as a barrier ...
The first Ethyl-2-Cyanoacrylate tissue adhesive in a tube that is more economical than sutures!...
Medicine Products: